Blog
China Health Pulse: Insights from the Founder
Keep up to date on the latest perspectives on health policy, innovation and China’s evolving health system.
Read newsletter here.
__________________________________________________________
Publications
Health Affairs – Unraveling Progress: The US Exit From The WHO And Its Global Consequences.
__________________________________________________________
Interviews
The Telegraph – China ramps up investment in the Health Silk Road.
__________________________________________________________
News
2024 Digital Health Panel at World Health Organisation Headquarters in Geneva, Switzerland
LINTRIS Health founder Ruby Wang was invited to moderate the “Impact of Tech on Global Health” panel at WHO Headquarters in July 2024, alongside Andy Pattison, WHO Digital Channels Lead, Awa Babington-Ashaye, Ph.D, founder of ADENIUM HEALTHCARE & Riccardo Lampariello, CEO of D-tree, as part of a National Committee on U.S.-China Relations Global Health Experts Seminar.
The three day conference also heard from health leaders incl Ilona Kickbusch of Geneva Graduate Institute global health centre, Joel Rehnstrom prev of UNAIDS, Judith Moore at World Economic Forum, as well as health attaches of US & China missions to UN Matthew Lim and Shi Qi, as well as NCUSCR president Stephen Orlins, and Schwarzman Scholars Senior Director & China Health expert Joan Kaufman, on topics including global health governance/pandemic treaty, health financing, health diplomacy, climate x health.
2024 London Business School’s China Business Forum
Dr Wang was invited to speak at London Business School’s 13th China Business Forum in May 2024 in the “Healthcare Investments” panel moderated by Dr. Jerry Wu , alongside Dan Liu , Rui Ma and Wei Peng. Topics discussed covered the most recent advances in digital health, not only for advancing clinical outcomes and optimising care system operations in order to solve shared UK-China health challenges such as ageing populations and pandemic potential disease but also in addressing innovation, biotech R&D and personalised medicine – starting from the lab.
2024 UK-China Health Policy Exchange on Chronic Obstructive Pulmonary Disease
On 1st February 2024, LINTRIS Health was proud to lead the project delivery of the 2024 UK-China Policy Exchange on Chronic Obstructive Pulmonary Disease, a high-level collaboration between China Centre for Economic Exchanges and the British Embassy Beijing.
COPD is one of the major chronic diseases for the global population. It presents huge health burdens for China today – a challenge that is shared by the UK.
This technical exchange across key senior experts across both countries enabled sharing of best practices on sustainability and affordability of COPD management in Primary Care.
For this bilateral exchange, British Embassy Beijing’s Foreign, Commonwealth and Development Office Minister Counsellor Matthew Moody and Department for Business and Trade Health Counsellor Rahul Agarwal met with CCIEE’s Minister Bi Jingquan. Experts on respiratory and primary care across UK and China government, academia and clinical practice, came together in person in Beijing and online from the UK to engage in meaningful exchanges.
UK Key Opinion leaders included Prof Sir Chris Ham, CoChair NHS Assembly, previous CEO The King’s Fund and Sarah Woolnough, current CEO, The King’s Fund; Dr Jonathan Fuld and Dr Kiren Collison, Directors of Respiratory and Primary Care at NHS England, Dr Katherine Hickman, Exec Chair at UK Primary Care Society, Dr Richard Russell, Clinical Director, Hampshire Community Integrated Respiratory Service, Prof Sir Peter J. Barnes FRS, FMedSci of the National Heart & Lung Institute and Rt Hon. Prof. Paul Burstow, former UK Minister of Health, Kasey Tobin from Department of Health and Social Care.
2023 The China Project Entrepreneurship Award
In May 2023, LINTRIS Health received the prestigious Entrepreneurship Award at the SupChina Women’s Gala in New York, hosted by The China Project. It was an honour to be recognised for our achievements.
LINTRIS 